FDA Approves New Drug, Endari, for Sickle Cell Disease

FRIDAY, July 7, 2017 -- The U.S. Food and Drug Administration on Friday approved the first new drug for sickle cell disease in nearly two decades. Endari (L-glutamine oral powder) helps reduce severe complications associated with the blood...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news